Validation of Epidemiological Methods for Studying the Infection Risk in Rheumatoid Arthritis with Methotrexate Combined Biologicals using Propensity Scores
{"title":"Validation of Epidemiological Methods for Studying the Infection Risk in Rheumatoid Arthritis with Methotrexate Combined Biologicals using Propensity Scores","authors":"Takuma Koinuma, M. Akazawa","doi":"10.3820/jjpe.26.e3","DOIUrl":null,"url":null,"abstract":"Probability Weighting Estimator(IPW)and Augmented Inverse Probability Weighting Estimator(AIPW) analyses. Results :The Odds Ratios(OR)estimated by each method using the time axis of the elapsed time, the prescription number, and the administration time were 1.48(95%CI 0.71-3.11), 1.60(95%CI 0.72-3.55), and 1.04(95%CI 0.58-1.86), respectively. We performed PS weighting, of each Average Treatment Effect obtained from IPW, and the AIPW were estimated to be 0.31%(95%CI −0.91-1.53)and 0.29%(95%CI −0.91-1.49), respectively, and the average treatment effect on the treated was estimated to be 0.10% (95%CI −1.11-1.32). We support the findings of a previous study which showed that the combination of biologicals was not statistically associated with increased infection risk. Conclusion :This study suggests that estimators from different perspectives might be obtained by using some epidemiological methods. Therefore, our results could contribute to the establishment of an improved methodology.","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3820/jjpe.26.e3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Probability Weighting Estimator(IPW)and Augmented Inverse Probability Weighting Estimator(AIPW) analyses. Results :The Odds Ratios(OR)estimated by each method using the time axis of the elapsed time, the prescription number, and the administration time were 1.48(95%CI 0.71-3.11), 1.60(95%CI 0.72-3.55), and 1.04(95%CI 0.58-1.86), respectively. We performed PS weighting, of each Average Treatment Effect obtained from IPW, and the AIPW were estimated to be 0.31%(95%CI −0.91-1.53)and 0.29%(95%CI −0.91-1.49), respectively, and the average treatment effect on the treated was estimated to be 0.10% (95%CI −1.11-1.32). We support the findings of a previous study which showed that the combination of biologicals was not statistically associated with increased infection risk. Conclusion :This study suggests that estimators from different perspectives might be obtained by using some epidemiological methods. Therefore, our results could contribute to the establishment of an improved methodology.